These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8213559)

  • 1. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.
    Buja G; Miorelli M; Turrini P; Melacini P; Nava A
    Am J Cardiol; 1993 Oct; 72(12):973-6. PubMed ID: 8213559
    [No Abstract]   [Full Text] [Related]  

  • 2. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Casey SA; Almquist AK
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):263. PubMed ID: 10090231
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy.
    Gilligan DM; Missouris CG; Boyd MJ; Oakley CM
    Am J Cardiol; 1991 Oct; 68(9):971-3. PubMed ID: 1927963
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Chang AC; McAreavey D; Fananapazir L
    Curr Opin Cardiol; 1995 Jan; 10(1):9-15. PubMed ID: 7787270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events.
    Grimm W; Steder U; Menz V; Hoffmann J; Maisch B
    Clin Cardiol; 1997 Feb; 20(2):107-10. PubMed ID: 9034638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
    J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.
    Kwon DH; Desai MY
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):85-7. PubMed ID: 17541762
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
    Spirito P; Rapezzi C; Autore C; Bruzzi P; Bellone P; Ortolani P; Fragola PV; Chiarella F; Zoni-Berisso M; Branzi A
    Circulation; 1994 Dec; 90(6):2743-7. PubMed ID: 7994816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Fauchier L; Babuty D; Cosnay P; Fauchier JP
    J Am Coll Cardiol; 1999 Apr; 33(5):1203-7. PubMed ID: 10193717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual causes of sudden cardiac death due to ventricular tachyarrhythmias.
    Gillis AM; Hamilton RM; LeFeuvre CA
    Can J Cardiol; 2000 Jun; 16 Suppl C():34C-40C. PubMed ID: 10887277
    [No Abstract]   [Full Text] [Related]  

  • 13. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
    Rowin EJ; Burrows A; Madias C; Estes NAM; Link MS; Maron MS; Maron BJ
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008123. PubMed ID: 32897759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death: better understanding of risks, mechanisms, and treatment.
    Lopshire JC; Zipes DP
    Circulation; 2006 Sep; 114(11):1134-6. PubMed ID: 16966594
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the corrected QT before the onset of nonsustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Baranowski R; Chojnowska L; Michalak E; Orłowska-Baranowska E
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):387-9. PubMed ID: 12687851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest.
    Miorelli M; Buja G; Melacini P; Fasoli G; Nava A
    Int J Cardiol; 1994 Jun; 45(2):121-7. PubMed ID: 7960250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D; Kubac G; Klinke WP
    Can J Cardiol; 1989 Mar; 5(2):77-80. PubMed ID: 2706577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.